2023 - Research.com Medicine in Japan Leader Award
Takeshi Kimura mostly deals with Internal medicine, Surgery, Cardiology, Percutaneous coronary intervention and Stent. His study ties his expertise on Endocrinology together with the subject of Internal medicine. His Surgery study integrates concerns from other disciplines, such as Coronary artery disease and Radiology, Angioplasty.
His Angioplasty research is multidisciplinary, incorporating perspectives in Coronary arteries and Balloon. Takeshi Kimura combines subjects such as Clopidogrel, Randomized controlled trial and Conventional PCI with his study of Percutaneous coronary intervention. His Stent research includes elements of Odds ratio, Drug, Everolimus and Revascularization.
Internal medicine, Cardiology, Surgery, Percutaneous coronary intervention and Myocardial infarction are his primary areas of study. In the field of Internal medicine, his study on Heart failure, Conventional PCI, Coronary artery disease and Hazard ratio overlaps with subjects such as In patient. His Cardiology research includes themes of Stroke and Incidence.
Within one scientific family, Takeshi Kimura focuses on topics pertaining to Angioplasty under Surgery, and may sometimes address concerns connected to Balloon. The study incorporates disciplines such as Clopidogrel, Acute coronary syndrome, Revascularization and Cohort in addition to Percutaneous coronary intervention. His studies deal with areas such as Thrombosis and Everolimus as well as Stent.
Takeshi Kimura spends much of his time researching Internal medicine, Cardiology, Percutaneous coronary intervention, Heart failure and Myocardial infarction. Takeshi Kimura connects Internal medicine with In patient in his research. His research integrates issues of Stroke and Clinical endpoint in his study of Cardiology.
His Percutaneous coronary intervention research is multidisciplinary, relying on both Stent, Clopidogrel, Conventional PCI and Dabigatran. His Heart failure research incorporates themes from Lower risk and Stenosis, Aortic valve replacement. His Stenosis study combines topics in areas such as Asymptomatic and Surgery.
His primary areas of study are Internal medicine, Cardiology, Percutaneous coronary intervention, In patient and Heart failure. His Myocardial infarction, Hazard ratio, Incidence, Atrial fibrillation and Randomized controlled trial study are his primary interests in Internal medicine. His Myocardial infarction research focuses on subjects like Coronary artery disease, which are linked to Emergency medicine.
His Cardiology research is multidisciplinary, incorporating elements of Percutaneous and Adverse effect. The various areas that Takeshi Kimura examines in his Percutaneous coronary intervention study include Stent, Coronary stent, Clinical trial and Conventional PCI. His Stent study deals with the bigger picture of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients
Masakiyo Nobuyoshi;Takeshi Kimura;Hideyuki Nosaka;Sokei Mioka.
Journal of the American College of Cardiology (1988)
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Christopher P. Cannon;Deepak L. Bhatt;Jonas Oldgren;Gregory Y.H. Lip.
The New England Journal of Medicine (2017)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini;Giuseppe Biondi-Zoccai;Diego Della Riva;Christoph Stettler.
The Lancet (2012)
Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes : The J-CTO (Multicenter CTO Registry in Japan) Score as a Difficulty Grading and Time Assessment Tool
Yoshihiro Morino;Mitsuru Abe;Takeshi Morimoto;Takeshi Kimura.
Jacc-cardiovascular Interventions (2011)
Training and simulation for patient safety
Rajesh Aggarwal;Oliver T. Mytton;Milliard Derbrew;David Hananel.
Quality & Safety in Health Care (2010)
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
Kimura T;Yokoi H;Nakagawa Y;Tamura T.
The New England Journal of Medicine (1996)
Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.
Yasuhide Kuwabara;Koh Ono;Takahiro Horie;Hitoo Nishi.
Circulation-cardiovascular Genetics (2011)
Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.
Masakiyo Nobuyoshi;Takeshi Kimura;Hiroto Ohishi;Hisanori Horiuchi.
Journal of the American College of Cardiology (1991)
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk
Philip Urban;Roxana Mehran;Roisin Colleran;Dominick J. Angiolillo.
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe;Takenori Domei;Takeshi Morimoto;Masahiro Natsuaki.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: